Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

14 hrs ago |

HCA Holdings Moves Up In Market Cap Rank, Passing Cardinal Health

Market capitalization is an important data point for investors to keep an eye on, for various reasons.


Related Topix: Biotech, Cardinal Health, Medicine, Healthcare Industry, Incentive Solutions, Allegiance, Financial Markets

18 hrs ago |

Paychex Becomes #6 Most Shorted Nasdaq 100 Component, Replacing Mylan

The most recent short interest data has been released by the NASDAQ for the 06/30/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover."


Related Topix: Paychex, SurePayroll, Human Resources, Dey, Biotech, Startups, Medicine, Mylan Laboratories, Healthcare Industry, Financial Markets

Fri Jul 11, 2014

Pharmacy Times

Generic Product News

Omega-3-Acid Ethyl Esters Capsules, USP, Marketed by: Teva Pharmaceutical Industries Ltd Compare to: Lovaza Indication: Teva Pharmaceutical Industries Ltd announces the approval of Omega-3-Acid Ethyl Esters Capsules, USP, a generic equivalent to GlaxoSmithKline's Lovaza.


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, GlaxoSmithKline, Dovonex, Calcipotriene (generic), Betamethasone (generic), Diprolene

Seeking Alpha

Mylan set to buy Abbott drug assets

Reuters reports that generic drug firm Mylan is in advanced negotiations with Abbott Laboratories to purchase a multibillion dollar portfolio of its established off-patent Europe-based drugs.


Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Abbott Laboratories

Pharmaceutical Technology

Dissolution Problems Spur Three Recalls

In its July 9, 2014 weekly enforcement report, FDA reported three voluntary drug product recalls from three different manufacturers due to dissolution problems.


Related Topix: Biotech, Medicine, Caraco Pharmaceutical Laboratories, Healthcare Industry, World News, India,


U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug

Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.


Related Topix: Gilead Sciences, Biotech, Medicine, Healthcare Industry, Hepatitis, Health, US News, US Senate, Ron Wyden, Democrat, US Politics, Startups, Pharmasset


India's Sun Pharma recalls over 40,000 bottles of antidepressant

India's Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the U.S. Food and Drug Administration said.


Related Topix: Sun Chemical, Chemicals, Medicine, Effexor, Venlafaxine (generic), Food and Drug Administration, Biotech, Caraco Pharmaceutical Laboratories, Healthcare Industry

Sun Pharma recalls antidepressant drug from US market

According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification.


Related Topix: Medicine, Effexor, Venlafaxine (generic), Biotech, Caraco Pharmaceutical Laboratories, Healthcare Industry

Thu Jul 10, 2014


Pharmacists want NHIA funds released

The Ghana Chamber of Pharmacy has said it will not be able to supply medicines and medical consumables to health institutions that are in arrears beyond two months.


Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The financ... )--E2open, Inc. , the leading provider of strategic, cloud-based software solutions for collaborative planning and execution across global trading n... )--Artisan Partners Asset Management Inc. today reported that its assets under management as of June 30, 2014 totaled $112.0 billion.


Related Topix: Startups, Biotech, Medicine, McKesson, Household Products, Healthcare Industry, Silicon Image, Integrated Device Technology


Takeda Pharmaceutical Co. Ltd. And Zinfandel Pharmaceuticals Inc. To ...

Takeda Pharmaceutical Company Limited and its partner, Zinfandel Pharmaceuticals, Inc. , will present data during multiple poster and oral sessions at the upcoming Alzheimer's Association International ConferenceA 2014 , taking place in "Studies show that individuals with mild cognitive impairmenta slight, although noticeable and measurable decline ... (more)


Related Topix: Takeda Pharmaceutical Company, Millennium Pharmaceuticals, Actos, Pioglitazone (generic), Medicine

Teva Pharmaceutical Industries Ltd Given Consensus Recommendation of...

Teva Pharmaceutical Industries Ltd has earned an average rating of "Buy" from the twenty-four analysts that are presently covering the company, AnalystRatingsNetwork reports .


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry

Pharmaceutical Processing

Bristol-Myers Squibb Makes Plans to Submit Biologics License Application for OpdivoA

Bristol-Myers Squibb Company today announced that, following discussions with the U.S. Food and Drug Administration , the company is planning a third quarter submission of a Biologics Licensing Application for OpdivoA for previously treated advanced melanoma.


Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Healthcare Law, Law


Covance Inc. Increases Its Medical And Scientific Leadership With Two Senior-Level Appointments

Dr. Robert Wasserman named Vice President and Global Therapeutic Area Head, Oncology and Dr. Rogelio Mosqueda-Garcia named Global Vice President, Early Clinical Services within Medical & Scientific Affairs Princeton, N.J. - July 9, 2014 - Covance today announced two key additions to its clinical development services scientific leadership team with ... (more)


Related Topix: Biotech, Medicine, Healthcare Industry, Covance, Oncology, Princeton, NJ, Pharmacology

Wed Jul 09, 2014

Insider Selling: Llew Keltner Sells 10,000 Shares of Raptor Pharmaceutical Corp. Stock

Raptor Pharmaceutical Corp. Director Llew Keltner sold 10,000 shares of the stock in a transaction that occurred on Monday, July 7th.


Related Topix: Raptor Pharmaceuticals

Hispanic Business

Actavis Completes Forest Laboratories Acquisition

"Our business model is driven by a broad portfolio of strong brand, generic and OTC products, a commitment to development-focused, results oriented research and development and the size and scale needed to efficiently and cost-effectively meet the needs of our global customer base.


Related Topix: Marketing

The Washington Post

Servier to Teva Fined $583 Million on Generic-Drug Delays

Les Laboratoires Servier and five makers of generic drugs, including Teva Pharmaceutical Industries Ltd., were fined 427.7 million euros by the European Union over agreements that delayed the release of cheaper versions of a hypertension treatment.


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Hypertension, Health, Inventions, Science / Technology, Aceon, Perindopril (generic), Mylan Laboratories


EU fines Teva for blocking cheaper generic drugs

European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros on Wednesday for blocking cheaper generic medicine.


Pharmaceutical Executive

Capturing the Real Value from a Pharma Spinout

The pharma spin market is poised to move into high gear as companies see the imperative to tap corporate brand value to retain shareholder confidence.


Tue Jul 08, 2014

Scientists exposed to potassium cyanide at Barr Laboratories in Pomona

Hazmat crews were on the scene Tuesday in Pomona after scientists were exposed to a dangerous chemical at a laboratory.


Related Topix: Biotech, Medicine, Barr Laboratories, Healthcare Industry


Pharmaceuticals Jobs